|
CLINT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62558855265615E-12 |
| Normal-vs-Stage2 |
5.64720004092578E-09 |
| Normal-vs-Stage3 |
1.751600E-02 |
| Normal-vs-Stage4 |
2.686200E-01 |
| Stage1-vs-Stage2 |
9.791800E-01 |
| Stage1-vs-Stage3 |
1.461410E-01 |
| Stage1-vs-Stage4 |
3.030600E-01 |
| Stage2-vs-Stage3 |
1.834250E-01 |
| Stage2-vs-Stage4 |
3.117600E-01 |
| Stage3-vs-Stage4 |
8.165800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62625468647093E-12 |
| Normal-vs-AfricanAmerican |
1.54000034946478E-10 |
| Normal-vs-Asian |
1.188970E-01 |
| Caucasian-vs-AfricanAmerican |
3.643200E-01 |
| Caucasian-vs-Asian |
4.740600E-01 |
| AfricanAmerican-vs-Asian |
6.648200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.99760216648792E-15 |
| Normal-vs-Female |
1.52060000147003E-08 |
| Male-vs-Female |
2.964200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.244000E-04 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
3.38620242956722E-11 |
| Normal-vs-Extreme_Obese |
1.798490E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.442160E-01 |
| Normal_Weight-vs-Obese |
8.104800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.703400E-01 |
| Extreme_Weight-vs-Obese |
1.973950E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.126000E-01 |
| Obese-vs-Extreme_Obese |
7.660200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.60160999999048E-05 |
| Normal-vs-Age(41-60Yrs) |
2.12080020212113E-10 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.607130E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.206600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.924500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.782600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.526220E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.678400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.714600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
5.75779999999471E-05 |
| Normal-VS-KIRP CIMP |
4.629800E-02 |
| Normal-VS-Unclassified PRCC |
1.46780000043201E-07 |
| Type1 PRCC-VS-Type2 PRCC |
8.977800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.109950E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.894300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.869600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.303600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.840600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.34119999994908E-07 |
| Normal-vs-N1 |
1.705510E-02 |
| Normal-vs-N2 |
1.643670E-03 |
| N0-vs-N1 |
1.159830E-01 |
| N0-vs-N2 |
9.370200E-01 |
| N1-vs-N2 |
4.140200E-01 |
|
|
